A
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
Price:
3.52
THB
0.57%
Market Closed
Market Cap:
฿1.5B
Income Statement
Earnings Waterfall
Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical & Agricultural Laboratory & Research Center PCL
Income Statement
Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical & Agricultural Laboratory & Research Center PCL
Currency: THB
| Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
5
|
6
|
5
|
4
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
|
| Revenue |
384
N/A
|
263
-31%
|
264
+0%
|
267
+1%
|
276
+3%
|
289
+5%
|
300
+4%
|
313
+4%
|
331
+6%
|
345
+4%
|
372
+8%
|
455
+22%
|
483
+6%
|
491
+2%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(123)
|
(66)
|
(115)
|
(121)
|
(124)
|
(181)
|
(234)
|
(239)
|
(274)
|
(205)
|
(212)
|
(222)
|
(226)
|
(226)
|
|
| Gross Profit |
261
N/A
|
197
-24%
|
149
-25%
|
146
-2%
|
152
+4%
|
108
-28%
|
66
-39%
|
74
+11%
|
57
-23%
|
140
+144%
|
160
+14%
|
232
+45%
|
257
+11%
|
265
+3%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(210)
|
(173)
|
(131)
|
(133)
|
(139)
|
(93)
|
(46)
|
(48)
|
(22)
|
(99)
|
(103)
|
(107)
|
(106)
|
(107)
|
|
| Selling, General & Administrative |
(207)
|
(174)
|
(133)
|
(135)
|
(142)
|
(97)
|
(50)
|
(53)
|
(27)
|
(102)
|
(106)
|
(110)
|
(109)
|
(111)
|
|
| Other Operating Expenses |
(3)
|
1
|
2
|
3
|
3
|
5
|
5
|
5
|
5
|
3
|
3
|
3
|
3
|
4
|
|
| Operating Income |
51
N/A
|
24
-53%
|
18
-25%
|
13
-28%
|
13
-2%
|
16
+22%
|
20
+29%
|
26
+25%
|
35
+37%
|
41
+17%
|
57
+39%
|
125
+119%
|
151
+20%
|
158
+5%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(10)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
41
N/A
|
18
-56%
|
13
-28%
|
9
-32%
|
10
+10%
|
13
+32%
|
18
+41%
|
23
+30%
|
33
+41%
|
40
+21%
|
56
+41%
|
124
+123%
|
150
+21%
|
157
+5%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(5)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
0
|
1
|
3
|
3
|
1
|
|
| Income from Continuing Operations |
36
|
15
|
9
|
6
|
7
|
10
|
15
|
20
|
30
|
40
|
57
|
127
|
153
|
159
|
|
| Net Income (Common) |
36
N/A
|
15
-60%
|
9
-35%
|
6
-42%
|
7
+19%
|
10
+46%
|
15
+53%
|
20
+36%
|
30
+51%
|
40
+32%
|
57
+43%
|
127
+122%
|
153
+21%
|
159
+4%
|
|
| EPS (Diluted) |
0.08
N/A
|
0.03
-63%
|
0.02
-33%
|
0.01
-50%
|
0.02
+100%
|
0.02
N/A
|
0.03
+50%
|
0.04
+33%
|
0.07
+75%
|
0.1
+43%
|
0.14
+40%
|
0.3
+114%
|
0.36
+20%
|
0.38
+6%
|
|
Switch to:
Switch to:
See Also
Discover More
